Lannett Company, Inc. is a leading manufacturer of high-quality, affordable generic pharmaceutical products. Headquartered in Trevose, Pennsylvania, it has US-based headquarters and manufacturing facilities and has been operating for over 75 years.
Subscribe to see Lannett’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Lannett is a pharma company headquartered in United States. Xcout tracks 10 named people at Lannett, including Timothy C. Crew (Chief Executive Officer).
4 more named people on record for Lannett, with roles, board committees and tenure — see the full roster →
A few of Lannett's closest competitors — see the full list of competitors and alternatives →
Egalet Corporation is a fully integrated specialty pharmaceutical company headquartered in Pennsylvania focused on developing, manufacturing, and commercializing treatments.
Endo, Inc. is a Pennsylvania-based company incorporated as a Delaware corporation that operates pharmaceutical businesses, including Endo Pharmaceuticals, with executive offices located in Pennsylvania.
Akorn, Inc. is a pharmaceutical company with its main headquarters located in Lake Forest, Illinois, alongside various manufacturing and operational facilities.
Founded in 2003, Nexus Pharmaceuticals is a US-based, family-owned, and minority-led pharmaceutical manufacturer that specializes in innovative processes to produce difficult-to-manufacture injectable drugs.
APPCO Pharma LLC is a U.S.-based pharmaceutical company that provides drug development, manufacturing, and analytical services. It offers formulation development, manufacturing, and analytical validation services for pharmaceutical products, while introducing high-quality and affordable drug products to the market.
Nivagen Pharmaceuticals, Inc. is a U.S.-based pharmaceutical company that develops, manufactures, and markets generic and specialty prescription medicines, including oral and injectable products. It serves healthcare providers, hospitals, pharmacies, and patients in the United States.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.